
doi: 10.1002/cpt197213178
pmid: 4550324
Nalbuphine is a narcotic antagonist and analgesic. A dose of 8 mg. per 70 Kg. of nalbuphine in man produces subjective effects which resemble those of 10 mg. per 70 Kg. of morphine. Nalbuphine, in doses of 24 and 72 mg. per 70 Kg., produces mild effects which more closely resemble those of nalorphine. Nalbuphine is ¼ as potent as nalorphine in precipitating abstinence in subjects dependent on 60 mg. of morphine per day. Chronic administration of nalbuphine produces physical dependence which resembles that produced by pentazocine, since it has elements of both morphine and nalorphine dependence. It is concluded that nalbuphine has an abuse potential which approximates that of pentazocine, but equianalgesic doses of nalbuphine produce less nalorphine‐like effects than does pentazocine.
Clinical Trials as Topic, Kinetics, Morphinans, Morphine, Substance-Related Disorders, Nalorphine, Humans, Cycloparaffins, Analgesia, Substance Withdrawal Syndrome
Clinical Trials as Topic, Kinetics, Morphinans, Morphine, Substance-Related Disorders, Nalorphine, Humans, Cycloparaffins, Analgesia, Substance Withdrawal Syndrome
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 132 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
